Anti-PIGL antibody produced in rabbit

N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (PIGL) is localized in the endoplasmic reticulum. It is a type I membrane protein with a large cytoplasmic domain. PIGL consists of 252-amino acid residues and contains the characteristic HXXEH zinc binding motif. The gene encoding this protein is located on chromosome 17p11.2.

N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase recombinant protein epitope signature tag (PrEST)

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (PIGL) is involved in the second step in glycosylphosphatidylinositol biosynthesis. It carries out the de-N-acetylation of N-acetylglucosaminylphosphatidylinositol (GlcNAc-PI). Mutations affecting the gene leads to coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation and ear anomalies syndrome (CHIME syndrome).

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Corresponding Antigen APREST71787

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany